Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

AUB

Atlantic Union Bankshares Corp

May 13 • 04:00PM ET

36.48

-0.56 -1.51 %

Financial • Banks - Regional • USA • Mid • NYSE

Peers: FNB HOMB UMBF SSB WSFS

| Held by: IJR VTI IWM VB VBR KRE VXF IJS SPSM IWN

Index	RUT	P/E	15.51	EPS (ttm)	2.35	Insider Own	0.99%	Shs Outstand	142.06M	Perf Week	-4.98%
Market Cap	5.22B	Forward P/E	9.13	EPS next Y	3.99	Insider Trans	0.05%	Shs Float	141.70M	Perf Month	-4.08%
Enterprise Value	-	PEG	0.68	EPS next Q	0.91	Inst Own	84.93%	Short Float	6.92%	Perf Quarter	-11.02%
Income	334.19M	P/S	2.34	EPS this Y	8.30%	Inst Trans	0.36%	Short Ratio	9.38	Perf Half Y	11.70%
Sales	2.23B	P/B	1.03	EPS next Y	7.22%	ROA	1.12%	Short Interest	9.81M	Perf YTD	3.34%
Book/sh	35.56	P/C	-	EPS next 5Y	13.43%	ROE	8.40%	52W High	42.18 -13.51%	Perf Year	16.03%
Cash/sh	-	P/FCF	12.59	EPS past 3/5Y	-11.96% 0.94%	ROIC	5.84%	52W Low	28.11 29.78%	Perf 3Y	54.58%
Dividend Est.	1.49 (4.08%)	EV/EBITDA	-	Sales past 3/5Y	38.40% 21.54%	Gross Margin	-	Volatility	2.40% 2.42%	Perf 5Y	-12.03%
Dividend TTM	1.42 (3.89%)	EV/Sales	-	EPS Y/Y TTM	7.08%	Oper. Margin	26.49%	ATR (14)	0.95	Perf 10Y	41.84%
Dividend Ex-Date	May 22, 2026	Quick Ratio	-	Sales Y/Y TTM	60.27%	Profit Margin	14.97%	RSI (14)	43.03	Recom	1.67
Dividend Gr. 3/5Y	6.21% 6.81%	Current Ratio	0.06	EPS Q/Q	61.05%	SMA20	-3.25%	Beta	0.79	Target Price	44.12
Payout	68.56%	Debt/Eq	0.28	Sales Q/Q	57.17%	SMA50	-0.22%	Rel Volume	1.09	Prev Close	37.04
Employees	3064	LT Debt/Eq	0.17	Earnings	Apr 21 BMO	SMA200	1.74%	Avg Volume	1.05M	Price	36.48
IPO	Oct 06, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.17% -2.69%	Trades		Volume	1,135,215	Change	-1.51%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-25	Downgrade	Raymond James	Strong Buy → Mkt Perform
Oct-08-25	Initiated	Janney	Buy
Sep-25-25	Initiated	TD Cowen	Buy	$46
Jun-10-25	Upgrade	Raymond James	Outperform → Strong Buy	$41
May-21-25	Initiated	Jefferies	Buy	$37
Mar-17-25	Reiterated	Hovde Group	Outperform	$46 → $40
Jan-27-25	Reiterated	Hovde Group	Outperform	$47 → $46
Jan-13-25	Resumed	Piper Sandler	Overweight	$51
Sep-13-24	Reiterated	Hovde Group	Outperform	$46 → $45
Jul-26-24	Reiterated	Hovde Group	Outperform	$40 → $46
Sep-13-23	Initiated	Stephens	Overweight	$36
Apr-06-23	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$42 → $36
Mar-03-23	Resumed	Raymond James	Outperform	$43
Dec-05-22	Resumed	Piper Sandler	Overweight	$42
Nov-29-22	Initiated	Hovde Group	Outperform	$41
Apr-22-22	Upgrade	Keefe Bruyette	Mkt Perform → Outperform
Dec-16-21	Upgrade	Piper Sandler	Neutral → Overweight	$41 → $42
Feb-18-21	Initiated	Seaport Global Securities	Buy
Jul-27-20	Resumed	Piper Sandler	Neutral
May-05-20	Upgrade	Stephens	Equal-Weight → Overweight

Show Previous Ratings

May-05-26 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
04:01PM	Atlantic Union Bankshares Corporation Announces $250 million Share Repurchase Program (Business Wire)
Apr-22-26 03:02AM	Atlantic Union Bankshares Corp (AUB) Q1 2026 Earnings Call Highlights: Strong Loan Growth and ... (GuruFocus.com)
Apr-21-26 04:43PM	Atlantic Union Bankshares Corporation Q1 2026 Earnings Call Summary (Moby)
06:53AM	Atlantic Union: Q1 Earnings Snapshot (Associated Press)
06:45AM	Loading…
06:45AM	Atlantic Union Bankshares Reports First Quarter Financial Results (Business Wire)
Mar-31-26 06:55AM	Atlantic Union Bankshares Corporation To Release First Quarter 2026 Financial Results (Business Wire)
Mar-10-26 02:27PM	Are Options Traders Betting on a Big Move in AUB Stock? (Zacks)
Mar-09-26 09:55AM	Atlantic Union (AUB) Could Find a Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Mar-05-26 03:28PM	Morgan Stanley Raises its Price Target on Atlantic Union Bankshares Corporation (AUB) to $47 and Maintains an Equal Weight Rating (Insider Monkey)
Mar-02-26 09:40AM	Are Finance Stocks Lagging Atlantic Union Bankshares (AUB) This Year? (Zacks)
Feb-27-26 04:40PM	Atlantic Union Bankshares, East West Bank, Coastal Financial, Wintrust Financial, and United Community Banks Shares Plummet, What You Need To Know (StockStory) -6.20%
Feb-26-26 06:45AM	Atlantic Union Bankshares Corporation to Present at Raymond James 47th Annual Institutional Investors Conference (Business Wire)
Feb-25-26 11:45AM	Atlantic Union (AUB) Could Be a Great Choice (Zacks)
Feb-24-26 06:55AM	Atlantic Union Bankshares Corporation Names Alexander D. Dodd Chief Financial Officer and Updates Transition Plan (Business Wire)
09:10AM	Loading…
Feb-23-26 09:10AM	How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks (Zacks)
Feb-16-26 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
09:05AM	What Makes Atlantic Union Bankshares Corporation (AUB) a High-Quality Bank Stock? (Insider Monkey)
Feb-15-26 11:01PM	3 Reasons to Sell AUB and 1 Stock to Buy Instead (StockStory)
Feb-09-26 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Feb-06-26 09:15AM	Orange County Bancorp, Inc. (OBT) Hits Fresh High: Is There Still Room to Run? (Zacks)
Feb-04-26 12:00PM	Atlantic Union (AUB) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Feb-02-26 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Jan-29-26 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
12:38AM	The 5 Most Interesting Analyst Questions From Atlantic Union Bankshares's Q4 Earnings Call (StockStory)
Jan-23-26 11:45AM	Atlantic Union (AUB) Could Be a Great Choice (Zacks)
12:31AM	AUB Q4 Deep Dive: Sandy Spring Integration and Core Loan Growth Shape 2025 Finish (StockStory)
Jan-22-26 04:02PM	Atlantic Union Bankshares Corp (AUB) Q4 2025 Earnings Call Highlights: Strong Loan Growth and ... (GuruFocus.com)
09:30AM	Atlantic Union (AUB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
07:45AM	Loading…
07:45AM	Atlantic Union (AUB) Q4 Earnings and Revenues Top Estimates (Zacks)
07:06AM	Atlantic Union Bankshares (NYSE:AUB) Beats Q4 CY2025 Sales Expectations (StockStory)
06:43AM	Atlantic Union: Q4 Earnings Snapshot (Associated Press Finance)
06:30AM	Atlantic Union Bankshares Reports Fourth Quarter and Full Year Financial Results (Business Wire)
Jan-21-26 05:34AM	Atlantic Union Bankshares (AUB) Q4 Earnings: What To Expect (StockStory) +7.04%
Jan-20-26 10:04PM	What To Expect From Atlantic Union Bankshares's (AUB) Q4 Earnings (StockStory)
Jan-16-26 10:00AM	Meridian Bank (MRBK) to Report Q4 Results: Wall Street Expects Earnings Growth (Zacks)
09:15AM	Countdown to Atlantic Union (AUB) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Jan-15-26 10:00AM	Atlantic Union (AUB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:05AM	This Regional Bank Offers Rare Trifecta Of Growth, Value and Yield (Investor's Business Daily)
Jan-12-26 09:49AM	SolaREIT Expands Revolving Credit Facility to $80 Million with Atlantic Union Bank and EagleBank (PR Newswire)
Jan-11-26 11:40PM	1 Bank Stock for Long-Term Investors and 2 Facing Challenges (StockStory)
06:00AM	2 regional bank stocks to own amid rising M&A activity (Yahoo Finance Video)
Jan-07-26 04:50PM	Banking: M&A activity will see 'very rapid' boost in 2026 (Yahoo Finance Video)
Jan-04-26 10:37PM	Winners And Losers Of Q3: Atlantic Union Bankshares (NYSE:AUB) Vs The Rest Of The Regional Banks Stocks (StockStory)
Dec-30-25 08:00AM	Atlantic Union Bankshares Corporation To Release Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Dec-09-25 11:38AM	NYSE Content Advisory: Market Update + Target Opens Newly Transformed 'Target SoHo' in New York (PR Newswire)
Nov-24-25 09:10AM	3 Top Dividend Stocks to Maximize Your Retirement Income (Zacks)
Nov-21-25 06:00PM	Atlantic Union Bankshares and Ameris Bancorp Stocks Trade Up, What You Need To Know (StockStory)
Nov-19-25 01:26PM	Is the Options Market Predicting a Spike in AUB Stock? (Zacks)
08:00AM	Atlantic Union Bankshares Corporation to Host Investor Day (Business Wire)
Nov-06-25 11:03PM	3 Reasons AUB is Risky and 1 Stock to Buy Instead (StockStory)
Oct-30-25 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
01:35AM	The Top 5 Analyst Questions From Atlantic Union Bankshares's Q3 Earnings Call (StockStory)
Oct-24-25 09:55AM	AUB Q3 Deep Dive: Sandy Spring Integration and Margin Pressures Shape Results (StockStory)
Oct-23-25 03:11PM	Atlantic Union Bankshares Corp (AUB) Q3 2025 Earnings Call Highlights: Navigating Growth Amid ... (GuruFocus.com)
09:30AM	Compared to Estimates, Atlantic Union (AUB) Q3 Earnings: A Look at Key Metrics (Zacks)
08:25AM	Atlantic Union Bankshares (NYSE:AUB) Posts Q3 Sales In Line With Estimates (StockStory)
07:55AM	Atlantic Union (AUB) Q3 Earnings and Revenues Lag Estimates (Zacks)
06:50AM	Atlantic Union: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Atlantic Union Bankshares Reports Third Quarter Financial Results (Business Wire)
Oct-22-25 09:26AM	Atlantic Union Bankshares Corp (AUB) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
08:45AM	Middlefield Banc Corp. (MBCN) Q3 Earnings and Revenues Top Estimates (Zacks)
Oct-21-25 11:01PM	What To Expect From Atlantic Union Bankshares's (AUB) Q3 Earnings (StockStory)
Oct-16-25 10:00AM	Atlantic Union (AUB) Earnings Expected to Grow: Should You Buy? (Zacks) -5.89%
Oct-15-25 11:45AM	Are You Looking for a High-Growth Dividend Stock? (Zacks)
Oct-14-25 12:51PM	Atlantic Union Bank Completes Integration of Sandy Spring Bank (Business Wire)
07:25AM	FB Financial (FBK) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
Oct-01-25 08:00AM	Atlantic Union Bankshares Corporation To Release Third Quarter 2025 Financial Results (Business Wire)
Sep-29-25 11:45AM	Why Atlantic Union (AUB) is a Great Dividend Stock Right Now (Zacks)
Sep-18-25 05:40PM	Atlantic Union Bankshares (AUB) Stock Is Up, What You Need To Know (StockStory)
Aug-25-25 12:00AM	3 Reasons to Sell AUB and 1 Stock to Buy Instead (StockStory)
Aug-10-25 11:32PM	A Look Back at Regional Banks Stocks' Q2 Earnings: Atlantic Union Bankshares (NYSE:AUB) Vs The Rest Of The Pack (StockStory)
Jul-25-25 07:03AM	Atlantic Union: Q2 Earnings Snapshot (Associated Press Finance)
Jul-24-25 04:01PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
08:05AM	Atlantic Union (AUB) Tops Q2 Earnings and Revenue Estimates (Zacks)
06:57AM	Atlantic Union Bankshares (NYSE:AUB) Surprises With Strong Q2 (StockStory)
06:50AM	Atlantic Union Bankshares Reports Second Quarter Financial Results (Business Wire)
Jul-23-25 09:33AM	What To Expect From Atlantic Union Bankshares Corp (AUB) Q2 2025 Earnings (GuruFocus.com)
Jul-22-25 11:01PM	Atlantic Union Bankshares (AUB) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-21-25 10:00AM	Analysts Estimate Merchants Bancorp (MBIN) to Report a Decline in Earnings: What to Look Out for (Zacks)
08:15AM	HBT Financial (HBT) Tops Q2 Earnings Estimates (Zacks)
Jul-17-25 10:00AM	Atlantic Union (AUB) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
12:00AM	Atlantic Union Bankshares (AUB): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-12-25 12:00PM	Blackstone Gobbles Up Another $2 Billion In Commercial Real Estate Loans (Benzinga)
Jul-02-25 06:59AM	Atlantic Union Bankshares Corporation To Release Second Quarter 2025 Financial Results (Business Wire)
Jun-27-25 02:26PM	Atlantic Union sells $2B CRE portfolio to Blackstone unit (American Banker)
Jun-26-25 04:57PM	Blackstone deepens CRE bet with $2 billion loan purchase from Atlantic Union (Reuters)
04:45PM	Atlantic Union Bank Closes Sale of Approximately $2 Billion of Commercial Real Estate Loans to Blackstone (Business Wire)
04:01PM	Blackstone Buys Another $2 Billion in Discounted Commercial Real-Estate Loans (The Wall Street Journal)
Jun-25-25 12:04AM	3 Reasons to Sell AUB and 1 Stock to Buy Instead (StockStory)
Jun-24-25 02:18AM	AUB Q1 Deep Dive: Loan Loss Reserve Build and Sandy Spring Acquisition Shape Results (StockStory)
Jun-18-25 12:03AM	Atlantic Union Bankshares (AUB): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-15-25 05:36AM	Raymond James Upgrades Atlantic Union Bankshares (AUB) Stock, Raises PT (Insider Monkey)
Jun-11-25 09:40AM	McDonalds downgraded on GLP-1 drug worries: Wall Streets top analyst calls (TipRanks)
May-22-25 06:59AM	Atlantic Union Bankshares Announces Planned Retirement of Robert M. Gorman, EVP and Chief Financial Officer (Business Wire)
May-13-25 07:00AM	Atlantic Union Bankshares Announces Appointment of Bradley S. Haun as Chief Risk Officer (Business Wire)
May-06-25 04:00PM	Atlantic Union Bankshares Corporation Declares Quarterly Common Stock Dividend and Preferred Stock Dividend (Business Wire)
Apr-26-25 10:03AM	Atlantic Union Bankshares Corporation (AUB): Among Billionaire Ken Fisher's Finance Stock Picks with Huge Upside Potential (Insider Monkey)
Apr-24-25 02:42PM	Atlantic Union Bankshares Corporation (AUB) Q1 2025 Earnings Call Transcript (Seeking Alpha)

Atlantic Union Bankshares Corp. is a bank holding company, which engages in the provision of financial services. It specializes in offering community banking services. Its services include checking, savings, lending, credit cards, online and mobile banking, treasury management, business eBanking, and wealth management. The company was founded in July 1993 and is headquartered in Glen Allen, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AGEE NANCY H	Director	Apr 20 '26	Buy	39.05	650	25,382	37,797	Apr 22 04:33 PM
Ellett Frank Russell	Director	Aug 08 '25	Buy	31.49	1,441	45,377	78,047	Aug 08 11:56 AM
Ellett Frank Russell	Director	Aug 06 '25	Buy	31.79	5,000	158,950	71,606	Aug 07 04:36 PM
Ellett Frank Russell	Director	Aug 07 '25	Buy	31.54	5,000	157,700	76,606	Aug 07 04:36 PM
Ellett Frank Russell	Director	Aug 05 '25	Buy	31.32	5,000	156,600	66,606	Aug 07 04:36 PM
Asbury John C	PRESIDENT AND CEO	Jul 28 '25	Buy	32.91	7,500	246,825	270,532	Jul 29 01:57 PM

Open in Screener

PGEN

Precigen Inc

May 13 • 04:00PM ET

4.15

+0.07 1.72 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: INO ALLO QURE SGMO FATE

| Held by: XBI VTI IWM VXF IWO FYC IBB SCHA VTWO KOMP

Index	RUT	P/E	-	EPS (ttm)	-1.40	Insider Own	56.55%	Shs Outstand	353.91M	Perf Week	-5.68%
Market Cap	1.47B	Forward P/E	27.67	EPS next Y	0.15	Insider Trans	-4.70%	Shs Float	153.79M	Perf Month	4.27%
Enterprise Value	1.47B	PEG	-	EPS next Q	-0.02	Inst Own	39.97%	Short Float	25.86%	Perf Quarter	-15.48%
Income	-429.64M	P/S	151.74	EPS this Y	96.61%	Inst Trans	5.01%	Short Ratio	8.87	Perf Half Y	3.75%
Sales	9.68M	P/B	70.23	EPS next Y	423.28%	ROA	-165.35%	Short Interest	39.77M	Perf YTD	-0.72%
Book/sh	0.06	P/C	15.01	EPS next 5Y	-	ROE	-571.97%	52W High	5.47 -24.06%	Perf Year	207.41%
Cash/sh	0.28	P/FCF	-	EPS past 3/5Y	-60.61% -6.02%	ROIC	-212.29%	52W Low	1.26 229.37%	Perf 3Y	291.51%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-28.87% -37.70%	Gross Margin	37.05%	Volatility	4.62% 4.88%	Perf 5Y	-35.16%
Dividend TTM	-	EV/Sales	151.78	EPS Y/Y TTM	-190.09%	Oper. Margin	-1100.78%	ATR (14)	0.22	Perf 10Y	-82.79%
Dividend Ex-Date	-	Quick Ratio	2.83	Sales Y/Y TTM	146.73%	Profit Margin	-4436.62%	RSI (14)	52.79	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	1.48%	SMA20	1.13%	Beta	1.05	Target Price	9.50
Payout	-	Debt/Eq	4.70	Sales Q/Q	283.61%	SMA50	8.42%	Rel Volume	0.60	Prev Close	4.08
Employees	160	LT Debt/Eq	4.65	Earnings	May 13 AMC	SMA200	7.95%	Avg Volume	4.48M	Price	4.15
IPO	Aug 08, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.48% 11.75%	Trades		Volume	2,711,909	Change	1.72%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-15-25	Upgrade	JP Morgan	Underweight → Neutral
Mar-22-24	Downgrade	JP Morgan	Neutral → Underweight
May-23-23	Initiated	JP Morgan	Neutral
Nov-18-22	Initiated	Cantor Fitzgerald	Overweight	$7
Feb-25-21	Initiated	Stifel	Buy	$13
Feb-22-21	Initiated	Wells Fargo	Overweight	$14
Feb-18-21	Initiated	B. Riley Securities	Buy	$10
May-08-20	Initiated	H.C. Wainwright	Buy	$5

Today 04:05PM	Precigen Reports First Quarter 2026 Financial Results and Business Updates (PR Newswire)
May-07-26 04:05PM	Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 (PR Newswire) -5.68%
Apr-07-26 07:00AM	Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million (ACCESSWIRE)
Mar-30-26 08:30AM	Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 (PR Newswire) -11.44%
Mar-25-26 11:02PM	Precigen Inc (PGEN) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion ... (GuruFocus.com) +25.48%
08:21PM	Loading…
08:21PM	Precigen, Inc. Q4 2025 Earnings Call Summary (Moby)
04:05PM	Precigen Reports Full Year 2025 Financial Results and Business Updates (PR Newswire)
Mar-11-26 04:05PM	Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 (PR Newswire)
Mar-05-26 08:50AM	CorMedix (CRMD) Lags Q4 Earnings Estimates (Zacks) -5.07%
08:40AM	Precigen (PGEN) Surged Following the Early Approval of Papziemos (Insider Monkey)
Feb-13-26 07:14AM	Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support (Insider Monkey)
Jan-20-26 08:05AM	New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis (PR Newswire)
Jan-12-26 08:00AM	Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire) -9.91%
Jan-05-26 04:05PM	Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire) +8.85%
Nov-14-25 12:01AM	Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... (GuruFocus.com) +25.65%
04:05PM	Loading…
Nov-13-25 04:05PM	Precigen Reports Third Quarter 2025 Financial Results and Business Updates (PR Newswire)
Nov-06-25 04:30PM	Precigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13 (PR Newswire)
Oct-26-25 06:05AM	Precigen Reports Positive Long-Term Follow-Up Data for FDA-Approved RRP Therapy, PAPZIMEOS (Insider Monkey)
Oct-13-25 07:00AM	Precigen Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS, the First and Only FDA-approved Therapy for Adults with Recurrent Respiratory Papillomatosis (PR Newswire)
Sep-23-25 07:23PM	Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization (Insider Monkey)
Sep-20-25 02:43AM	Precigen, Inc. (PGEN) Bolsters Financial Standing to Enhance PAPZIMEOS Commercialization (Insider Monkey)
Sep-15-25 08:17AM	Precigen Signs a Credit Facility Agreement Worth $125 Million to Support PAPZIMEOS (Insider Monkey) -5.28%
Sep-12-25 03:41AM	4 years from clinic to approval Precigens unprecedented FDA nod and what comes next (Pharma Voice) -8.45%
Sep-11-25 03:31AM	Precigen's (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism (Insider Monkey)
Sep-07-25 08:23AM	These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts (Motley Fool)
Sep-03-25 07:00AM	Precigen Announces Up to $125 Million Non-Dilutive Financing (PR Newswire)
Sep-02-25 12:57AM	Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) (Insider Monkey) +5.54%
Aug-28-25 10:00AM	INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug (Zacks)
Aug-26-25 08:39AM	Citizens JMP Raises PT on Precigen from $6 to $8, Keeps Outperform Rating (Insider Monkey) +7.04%
Aug-25-25 11:56PM	H.C. Wainwright Remains Bullish on Precigen (PGEN) (Insider Monkey)
11:04AM	Loading…
11:04AM	PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
08:05AM	Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright (PR Newswire)
Aug-20-25 12:22AM	Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment (Insider Monkey)
Aug-18-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
07:42AM	FDA approves Papzimeos as first therapy for HPV-caused airway disease (Pharmaceutical Technology)
Aug-15-25 10:45AM	Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP) (Business Wire) +58.92%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
07:20AM	Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial (BioPharma Dive)
07:00AM	Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis (PR Newswire)
May-14-25 04:05PM	Precigen Reports First Quarter 2025 Financial Results and Business Updates (PR Newswire) -5.19%
Apr-22-25 12:00PM	Patient Capital Management Q1 2025 Investment Review (Seeking Alpha) +11.68%
Apr-16-25 08:05AM	Precigen and Recurrent Respiratory Papillomatosis Foundation to Host the 2025 International RRP Awareness Day on June 11th (PR Newswire)
Mar-27-25 10:19AM	Is Precigen (PGEN) The Hot Biotech Stock Under $5? (InsiderMonkey)
Mar-21-25 06:23PM	Precigen Inc (PGEN) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-19-25 07:47PM	Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript (SeekingAlpha) +7.19%
06:25PM	Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Precigen Reports Full Year 2024 Financial Results and Business Updates (PR Newswire)
Mar-13-25 08:05AM	Precigen to Announce Full Year 2024 Financial Results and Provide Business Updates on March 19th (PR Newswire)
Mar-01-25 05:27PM	Why Precigen, Inc. (PGEN) is Skyrocketing So Far in 2025 (Insider Monkey)
Feb-25-25 08:05AM	FDA Grants Priority Review to Precigen's BLA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis with PDUFA Target Action Date Set for August 27, 2025 (PR Newswire)
Jan-13-25 07:00AM	Precigen to Present Plans for Realizing Commercial Vision for PRGN-2012 at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) -8.94%
Jan-09-25 08:30AM	Precigen to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-30-24 07:00AM	Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (PR Newswire) +28.47%
Dec-27-24 09:00AM	Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock (PR Newswire)
Nov-14-24 04:30PM	Precigen Reports Third Quarter 2024 Financial Results and Business Updates (PR Newswire) -7.11%
Nov-12-24 04:05PM	Precigen to Participate in the Stifel 2024 Healthcare Conference (PR Newswire) -5.04%
Sep-16-24 04:30PM	Precigen to Participate in the 2024 Cantor Global Healthcare Conference (PR Newswire)
Aug-14-24 04:05PM	Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates (PR Newswire)
01:54PM	Hedge Fund and Insider Trading News: Nelson Peltz, Jana Partners, Whitebox Advisors, Caxton Associates LP, Altium Capital, Soros Fund Management, Elliott Investment Management, Balyasny Asset Management, Precigen Inc (PGEN), Vulcan Materials Company (VMC), and More (Insider Monkey)
Aug-09-24 08:00AM	Precigen to Announce Second Quarter and First Half 2024 Financial Results on August 14th (PR Newswire) -13.39%
Aug-07-24 09:30PM	Precigen Announces Pricing of $30.0 Million Public Offering of Common Stock (PR Newswire) -12.59% +7.63%
Aug-06-24 04:04PM	Precigen Announces Proposed $30 Million Public Offering of Common Stock (PR Newswire)
04:01PM	Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch (PR Newswire)
Jul-23-24 08:01AM	Precigen Appoints Phil Tennant as Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch (PR Newswire)
Jun-03-24 09:30AM	Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response (PR Newswire) +11.43%
May-23-24 05:00PM	Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent Respiratory Papillomatosis Presented at the 2024 ASCO Annual Meeting (PR Newswire)
May-14-24 05:20PM	Precigen, Inc. (PGEN) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +5.11%
04:05PM	Precigen Reports First Quarter 2024 Financial Results and Business Updates (PR Newswire)
08:21AM	Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 04:05PM	Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual Meeting (PR Newswire)
Apr-24-24 10:20AM	Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting (PR Newswire)
09:00AM	Actym Therapeutics Appoints Thomas Smart as CEO (PR Newswire)
Mar-28-24 04:05PM	Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th (PR Newswire)
Mar-27-24 08:20AM	Analysts on Wall Street Lower Ratings for These 10 Stocks (Insider Monkey)
Mar-20-24 10:07AM	Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-19-24 08:53PM	PGEN Stock Earnings: Precigen Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:31PM	Precigen Inc (PGEN) Reports Full Year 2023 Financial Results (GuruFocus.com)
04:05PM	Precigen Reports Full Year 2023 Financial Results and Business Updates (PR Newswire)
Mar-12-24 04:05PM	Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Mar-05-24 04:05PM	Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th (PR Newswire)
Feb-06-24 04:05PM	Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference (PR Newswire)
Jan-16-24 08:05AM	Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission (PR Newswire)
Jan-08-24 08:30AM	Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) +8.53%
Jan-02-24 12:40PM	Hedge Fund and Insider Trading News: David Einhorn, Bill Ackman, D. E. Shaw, Steve Cohen, Rob Citrone, Saba Capital, HighPeak Energy, Inc (HPK), Precigen Inc (PGEN), and More (Insider Monkey) +5.22%
Dec-18-23 04:05PM	Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire) -5.74%
Nov-29-23 04:05PM	Precigen to Participate in the JMP Securities Hematology and Oncology Summit (PR Newswire)
Nov-09-23 04:55PM	Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs (PR Newswire) -13.49%
Nov-07-23 04:05PM	Precigen to Participate in the Stifel 2023 Healthcare Conference (PR Newswire) +12.93%
Sep-19-23 04:05PM	Precigen to Participate in Upcoming Leading Investor and Industry Conferences (PR Newswire) -8.33% +6.06%
Aug-09-23 08:00AM	Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025 (PR Newswire) +6.90%
07:05AM	Precigen Announces FDA Confirmation that the Ongoing Phase 1/2 Study of PRGN-2012 AdenoVerse Immunotherapy Will Serve as the Pivotal Study to Support Accelerated Approval (PR Newswire)
Aug-03-23 04:05PM	Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9th (PR Newswire) -6.67%
Jun-20-23 07:30AM	Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis (PR Newswire)
Jun-05-23 04:05PM	Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients (PR Newswire)
Jun-03-23 12:00PM	Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVerse Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers (PR Newswire)
May-31-23 08:05AM	Precigen Receives FDA Clearance of IND to Initiate Phase 2 Study of PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy in Combination with Pembrolizumab to Treat Patients with Recurrent or Metastatic Cervical Cancer (PR Newswire)
May-10-23 08:00AM	Precigen Reports First Quarter 2023 Financial Results and Business Updates (PR Newswire)
May-03-23 08:30AM	Precigen to Announce First Quarter 2023 Financial Results on May 10th (PR Newswire) +8.85%
Apr-26-23 04:05PM	Precigen to Present Latest Clinical Advancements for PRGN-3005 UltraCAR-T® and PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy at the 2023 ASCO Annual Meeting (PR Newswire)

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KIRK RANDAL J	Director	Mar 30 '26	Sale	3.30	4,772,781	15,750,177	302,213	Mar 31 04:10 PM
Randal J. Kirk	Director	Mar 30 '26	Proposed Sale	3.67	4,772,781	17,516,106		Mar 30 05:33 PM
KIRK RANDAL J	Director	Mar 13 '26	Option Exercise	0.00	143,678	0	81,781,816	Mar 16 05:29 PM
KIRK RANDAL J	Director	Dec 22 '25	Sale	4.18	1,900,036	7,942,150	341,189	Dec 22 08:48 PM
Randal J. Kirk	Director	Dec 22 '25	Proposed Sale	4.32	1,900,036	8,208,156		Dec 22 08:19 PM
KINDLER JEFFREY B	Director	Dec 12 '25	Sale	3.63	235,467	855,899	110,603	Dec 16 04:16 PM
Jeffrey Kindler	Director	Dec 12 '25	Proposed Sale	3.69	235,467	868,873		Dec 12 06:27 PM
KIRK RANDAL J	Director	Nov 19 '25	Sale	4.47	1,086,153	4,855,104	7,434,384	Nov 21 07:54 PM
KIRK RANDAL J	Director	Nov 20 '25	Sale	4.08	942,832	3,846,755	6,491,552	Nov 21 07:54 PM
KIRK RANDAL J	Director	Nov 21 '25	Sale	3.83	937,308	3,589,890	5,554,244	Nov 21 07:54 PM
KIRK RANDAL J	Director	Nov 20 '25	Proposed Sale	4.08	942,832	3,843,885		Nov 20 05:33 PM
KIRK RANDAL J	Director	Nov 19 '25	Proposed Sale	4.22	1,086,153	4,583,565		Nov 19 05:23 PM
KINDLER JEFFREY B	Director	Sep 30 '25	Sale	3.38	106,837	361,109	346,070	Oct 01 05:16 PM
KINDLER JEFFREY B	Director	Sep 29 '25	Sale	3.60	67,523	243,083	452,907	Oct 01 05:16 PM
KIRK RANDAL J	Director	Sep 30 '25	Sale	3.41	1,809,667	6,170,964	14,597,161	Sep 30 05:44 PM
KIRK RANDAL J	Director	Sep 30 '25	Proposed Sale	3.63	1,809,667	6,569,091		Sep 30 05:26 PM
Jeffrey Kindler	Director	Sep 30 '25	Proposed Sale	3.29	106,837	351,494		Sep 30 04:21 PM
Shah Rutul R	Chief Operating Officer	Sep 26 '25	Buy	3.40	2,000	6,800	405,959	Sep 30 04:07 PM
Tennant Phil	Chief Commercial Officer	Sep 29 '25	Buy	3.58	6,000	21,480	65,031	Sep 30 04:04 PM
Jeffrey Kindler	Director	Sep 29 '25	Proposed Sale	3.63	67,523	245,108		Sep 29 04:12 PM
Thomasian Harry Jr.	Chief Financial Officer	Sep 25 '25	Buy	3.62	8,284	29,988	465,694	Sep 26 05:01 PM
Thomasian Harry Jr.	Chief Financial Officer	Sep 26 '25	Buy	3.42	2,932	10,027	468,626	Sep 26 05:01 PM
KIRK RANDAL J	Director	Sep 19 '25	Sale	3.68	3,596,892	13,236,563	8,520,537	Sep 19 08:46 PM
KIRK RANDAL J	Director	Sep 18 '25	Sale	3.86	1,403,360	5,416,970	12,117,429	Sep 19 08:46 PM
KIRK RANDAL J	Director	Sep 19 '25	Proposed Sale	3.85	252	970		Sep 19 04:47 PM
KIRK RANDAL J	Director	Sep 18 '25	Proposed Sale	3.92	5,000,000	19,625,000		Sep 18 01:30 PM
AGEE NANCY H	Director	Sep 04 '25	Buy	4.60	15,000	69,000	217,841	Sep 05 05:46 PM
AGEE NANCY H	Director	Aug 28 '25	Buy	4.65	10,645	49,491	202,841	Aug 29 04:21 PM
AGEE NANCY H	Director	Aug 19 '25	Buy	3.20	15,360	49,152	192,196	Aug 29 04:21 PM

AUB

Atlantic Union Bankshares Corp

PGEN

Precigen Inc

Upgrade your Finviz experience